DK3856151T3 - Lyofilisat af treosulfan - Google Patents

Lyofilisat af treosulfan Download PDF

Info

Publication number
DK3856151T3
DK3856151T3 DK19778493.7T DK19778493T DK3856151T3 DK 3856151 T3 DK3856151 T3 DK 3856151T3 DK 19778493 T DK19778493 T DK 19778493T DK 3856151 T3 DK3856151 T3 DK 3856151T3
Authority
DK
Denmark
Prior art keywords
treosulfan
lyophilisate
Prior art date
Application number
DK19778493.7T
Other languages
English (en)
Inventor
Sebastian Bialleck
Original Assignee
Medac Ges Fuer Klinische Spezialpraeparate Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Ges Fuer Klinische Spezialpraeparate Mbh filed Critical Medac Ges Fuer Klinische Spezialpraeparate Mbh
Application granted granted Critical
Publication of DK3856151T3 publication Critical patent/DK3856151T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/08Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK19778493.7T 2018-09-26 2019-09-25 Lyofilisat af treosulfan DK3856151T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18196967 2018-09-26
PCT/EP2019/075832 WO2020064819A1 (en) 2018-09-26 2019-09-25 Lyophilisate of treosulfan

Publications (1)

Publication Number Publication Date
DK3856151T3 true DK3856151T3 (da) 2023-11-27

Family

ID=63685769

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19778493.7T DK3856151T3 (da) 2018-09-26 2019-09-25 Lyofilisat af treosulfan

Country Status (15)

Country Link
US (1) US12178914B2 (da)
EP (2) EP4257122B1 (da)
JP (3) JP7776985B2 (da)
CN (1) CN112752569B (da)
CA (1) CA3113705A1 (da)
DK (1) DK3856151T3 (da)
EA (1) EA202190616A1 (da)
ES (1) ES2964602T3 (da)
FI (1) FI3856151T3 (da)
HR (1) HRP20231343T1 (da)
HU (1) HUE064508T2 (da)
LT (1) LT3856151T (da)
PL (1) PL3856151T3 (da)
PT (1) PT3856151T (da)
WO (1) WO2020064819A1 (da)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB891466A (en) 1958-04-24 1962-03-14 Nat Res Dev New methane sulphonic acid esters of polyols
GB896052A (en) 1960-02-22 1962-05-09 Knud Abildgaard The stereo-isomers and the racemate of butane-1,2,3,4-tetrol-1,4-di-(methanesulphonate)
DE1188583B (de) 1960-02-22 1965-03-11 Leo Pharm Prod Ltd Verfahren zur Herstellung der Steroisomeren und des Racemats von Butan-1, 2, 3, 4-tetrol-1, 4-di-(methansulfonat)
DE1193938B (de) 1961-10-02 1965-06-03 Leo Pharm Prod Ltd Verfahren zur Herstellung des Racemats und der Stereoisomeren einschliesslich des Mesoisomeren von Butan-1, 2, 3, 4-tetrol-1, 4-di-(methansulfonat)
DE19936281C2 (de) 1999-08-02 2002-04-04 Bayer Ag Verfahren zur Gefriertrocknung
DE19953517C1 (de) 1999-11-05 2001-08-09 Medac Klinische Spezialpraep Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation
US8793895B2 (en) 2006-02-10 2014-08-05 Praxair Technology, Inc. Lyophilization system and method
AR077384A1 (es) 2010-07-05 2011-08-24 Eriochem Sa Una formulacion farmaceutica inyectable de melfalano.
EP2958554B1 (en) 2013-02-19 2018-06-06 Synthon BV Stable compositions of bendamustine
WO2015107534A1 (en) 2013-11-04 2015-07-23 Emcure Pharmaceuticals Limited Lyophilized formulation of treosulfan

Also Published As

Publication number Publication date
JP2022509904A (ja) 2022-01-25
JP7776985B2 (ja) 2025-11-27
EP4257122A3 (en) 2024-01-10
JP2025137705A (ja) 2025-09-19
HRP20231343T1 (hr) 2024-02-16
FI3856151T3 (fi) 2023-11-15
US12178914B2 (en) 2024-12-31
PT3856151T (pt) 2023-10-27
CA3113705A1 (en) 2020-04-02
CN112752569A (zh) 2021-05-04
CN112752569B (zh) 2025-07-04
HUE064508T2 (hu) 2024-03-28
LT3856151T (lt) 2023-11-27
EP4257122A2 (en) 2023-10-11
EP3856151B1 (en) 2023-08-23
ES2964602T3 (es) 2024-04-08
EP3856151A1 (en) 2021-08-04
EP4257122B1 (en) 2026-03-11
US20220031620A1 (en) 2022-02-03
EA202190616A1 (ru) 2021-06-25
PL3856151T3 (pl) 2024-02-19
WO2020064819A1 (en) 2020-04-02
JP2023153362A (ja) 2023-10-17

Similar Documents

Publication Publication Date Title
IL284508A (en) Irreversible inhibitors of menin-mll interaction
EP3773896A4 (en) Controlled release of radionuclides
DK3810581T3 (da) Krystalmodifikationer af odevixibat
DK4045039T3 (da) Hæmning af human integrin-alfa4beta7
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3684377T3 (da) Fremgangsmåder til behandling af hepatitis-b-infektion
DK3661514T3 (da) Mavacamten til behandling af hypertrofisk kardiomyopati
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
EP3801500A4 (en) Inhibitors of sarm1
DK3833662T3 (da) Inhibitorer af protein-protein-interaktionen mellem KEAP-1-NRF2-
DK3891145T3 (da) Modulatorer af trex1
EP3827689A4 (en) SHOE INSOLE
DK3436074T3 (da) Thiazolidforbindelser til behandling af virale infektioner
DK3517543T3 (da) Fremstilling af glucagonpeptider
DK3678648T3 (da) Fremgangsmåder til anvendelse af dipivefrin
DK3759745T3 (da) Dannelse af piezoelektriske anordninger
DK3807260T3 (da) Oprensning af nikotin
DK3474822T3 (da) Formuleringer af brincidofovir
EP3918492A4 (en) Managing geospatial boundaries
DK3585808T3 (da) Modificerede serpiner til behandlingen af bradykinin formidlet sygdom
EP3759680A4 (en) MODIFICATION OF WORKFLOWS IN THE FIELD
DK3678644T3 (da) Formuleringer af copanlisib
DK3743064T3 (da) Behandling af proteinuri
DK3630725T3 (da) Krystallinsk form af n-butyldeoxygalactonojirimycin